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Abstract
Objective: This study determined whether hypercholesterolemia would contribute to both the initiation and progression of angiotensin (Ang)II-induced
abdominal aortic aneurysms (AAAs) in mice.
Methods and Results: To determine whether hypercholesterolemia accelerates the initiation of AAAs, male low-density lipoprotein (LDL) receptor -/- mice
were either fed one week of Western diet prior to starting AngII infusion or initiated Western diet one week after starting AngII infusion. During the first week
of AngII infusion, mice fed normal diet had less luminal expansion of the suprarenal aorta compared to those initiated Western diet after the first week of AngII
infusion. The two groups achieved comparable luminal dilation on week 2 through week 6 of AngII infusion as monitored by ultrasound. To determine whether
hypercholesterolemia contributed to the progression of established AAAs, male LDL receptor -/- mice were fed Western diet and infused with AngII for 4
weeks. Mice with established AAAs were then stratified into two groups based on luminal diameters measured by ultrasound. While AngII infusion was continued
for another 8 weeks in both groups, mice in one group were continuously fed Western diet, but diet in the other group was switched to normal laboratory diet.
In the latter group, plasma cholesterol concentrations were reduced rapidly to approximately 500 mg/dl within one week after the diet was switched from
Western diet to normal laboratory diet. Luminal expansion progressed constantly in mice continuously fed Western diet, whereas no continuous expansion was
detected in mice that were switched to normal laboratory diet.
Conclusion: Hypercholesterolemia accelerates both the initiation of AAAs and progression of established AAAs in AngII-infused male LDL receptor -/mice.
Clinical Relevance: Hypercholesterolemia is modestly associated with AAAs in observational or retrospective clinical studies. It is not feasible to study
whether hypercholesterolemia contributes to the initiation of AAAs or progression of established AAAs in human. This study using AngII-induced AAA mouse
model provides solid evidence that hypercholesterolemia contributes to both the initiation and progression of AAAs, supporting that statin therapy at any stage
of AAA development may be beneficial to hypercholesterolemic patients with AAAs.

INTRODUCTION
Hypercholesterolemia augments development of angiotensin
II (AngII)-induced abdominal aortic aneurysms (AAAs) in male
mice [1-6]. This has been most commonly demonstrated in male
low-density lipoprotein (LDL) receptor -/- mice fed a Western
diet for one week prior to starting AngII infusion [7]. This one
week of Western diet feeding leads to profound increases of
plasma cholesterol concentrations to more than 1,000 mg/dl
[3]. It is unclear whether a pre-existing hypercholesterolemic

status is important to the initiation of AngII-induced AAAs, or it is
critical for the progression of pre-existing AAAs.

Plasma total cholesterol concentrations are below 300 mg/
dl in LDL receptor -/- mice fed normal laboratory diet, but
increase to more than 1,000 mg/dl within a week of Western diet
feeding [3,8-10]. This LDL receptor -/- mouse in combination
with diet manipulation provides a model to determine whether
hypercholesterolemia contributes to the initiation and
progression of AngII-induced AAAs. In this study using male LDL
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MATERIAL AND METHODS

In this study, we only used male mice because female LDL
receptor -/- mice have very low incidence of AngII-induced AAAs
[3,11,12]. All mouse experiments reported in this manuscript
were performed with the approval of the University of Kentucky
Institutional Animal Care and Use Committee (University of
Kentucky IACUC protocol number: 2006-0009).

Mini Osmotic Pump Implantation and Angiotensin II
Infusion

To induce AAAs, mice were infused with 1,000 ng/kg/min of
AngII (Cat # H-1705; Bachem, Torrance, CA, USA) subcutaneously
via Alzet mini osmotic pumps (Alzet Model # 2006; Durect Corp,
Cupertino, CA, USA).7 In first study (Figure 1A), one group of
mice started Western diet one week prior to AngII infusion
(WD group), whereas the other group started this Western diet
one week after initiating AngII infusion (ND - WD group). AngII
infusion duration was 6 weeks for both groups.
In second study (Figure 2A); all mice were fed Western
diet for one week prior to AngII infusion. Lumen diameters
of suprarenal aortas were measured using noninvasive high
frequency ultrasound system (Vevo 2100 with MS550D; FUJIFILM
VisualSonics, Toronto, ON, Canada) at baseline and on day 28 of
AngII infusion. AAAs were defined as 50% or more increase of
the maximal lumen diameter of the suprarenal aorta on day 28
compared to the baseline (day 0). Based on luminal diameter
measurements, mice exhibiting AAAs were stratified into two
groups, and then either continuously fed Western diet (WD
group) or switched to normal laboratory diet (WD - ND group).
These two groups were infused with AngII for an additional
8 weeks. The entire duration of AngII infusion was 12 weeks
achieved by implanting two mini osmotic pumps separately
(Alzet Model # 2006): One pump was implanted on day 0 and
replaced by a second pump on day 43. The second pump was
Ann Vasc Med Res 7(1): 1099 (2020)

2

B

C

1600
1200

D

*

*

*

Luminal Diameter (mm)

Male low-density lipoprotein (LDL) receptors -/- mice
(8 weeks old) were purchased from The Jackson Laboratory
(Stock # 2207; Bar Harbor, ME, USA). Mice were housed in
individually vented cages (5 mice/cage) on a light:dark cycle of
14:10 hours. The cage bedding was Teklad Sani-Chip bedding
(Cat # 7090A; Envigo, Madison, WI, USA). Mice were fed a
normal rodent laboratory diet (Diet # 2918; Envigo) and given
drinking water from a reverse osmosis system ad libitum. To
induce hypercholesterolemia, mice were fed a Western diet
supplemented with saturated fat extracted from milk (21% wt/
wt) and cholesterol (0.15% wt/wt supplemented and 0.05% wt/
wt from the fat source; Diet # TD.88137; Envigo). Mice died of
any reason prior to termination were excluded for data analyses.
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receptor -/- mice, we determined whether hypercholesterolemia
would promote the initiation of AngII-induced AAAs, and
whether maintaining hypercholesterolemia would modulate the
progression of established AAAs.
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Figure 1 Hypercholesterolemia accelerated the initiation of
AngII-induced AAAs in male LDL receptor -/- mice. (A) Mice in
WD group initiated Western diet feeding one week prior to AngII
infusion, and mice in ND - WD group initiated Western diet one week
after starting AngII infusion. The duration of AngII infusion was 6
weeks. (B) Plasma cholesterol concentrations were measured using
an enzymatic method. * P < 0.001, = 0.007, and < 0.001 between the
two groups on Week 0, 1, and 2, respectively. (C) Maximal luminal
diameters of suprarenal aortas were measured using ultrasound.* P =
0.004 on week 1. The orange arrow in (B) and (C) indicates the start of
Western diet feeding in ND - WD group. (D) Maximal outer diameters
of suprarenal aortas were measured using an ex vivo method. (E)
Atherosclerosis was measured by an en face method. * P = 0.008.
Triangles are values from individual mice. Circles represent means
and error bars represent SEM.

preincubated in saline at 37 ̊C for more than 60 hours to permit
immediate delivery of AngII after implantation of pumps in mice.

Ultrasonography

Luminal diameters of suprarenal aortas were measured using
a Vevo 2100 ultrasound imaging system at indicated intervals
[13]. Mice were anesthetized with isoflurane and restrained in
a supine position. Short-axis scan was performed from the level
of left renal artery moving vertically up to the suprarenal region.
One hundred frames of cine loops were acquired and the maximal
luminal diameter of the suprarenal aortic region was measured
on images during aortic dilation phase. Luminal diameters
were measured by one investigator, and verified by another
investigator independently who were blind to study groups.

Plasma cholesterol measurements

During each study, mice were bled consciously with
submandibular bleeding. At termination mice were anesthetized
using ketamine/xylazine cocktail, and blood samples were
harvested by right ventricular puncture. All blood samples
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Statistical analyses
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Figure 2 Hypercholesterolemia contributed to the progression of
established AAAs in male LDL receptor -/- mice. (A) Mice in both
groups started Western diet feeding one week prior to AngII infusion.
Mice in WD group had been fed Western diet during AngII infusion,
and diet for mice in WD - ND group was changed to normal laboratory
diet after 4 weeks of AngII infusion. AngII infusion duration for both
groups was 12 weeks. (B) Plasma cholesterol concentrations were
measured using an enzymatic method. * P < 0.001 on week 5, 6, and
12, respectively. (C) Maximal luminal diameters of suprarenal aortas
were measured with ultrasound. * P = 0.02 and <0.001 on week 6
and 12, respectively. The orange arrow in (B) and (C) indicates diet
was switched from Western diet to normal laboratory diet in WD ND group. (D) Maximal outer diameters of suprarenal aortas were
measured using an ex vivo method. * P < 0.001. (E) Atherosclerosis
was measured by an en face method. * P < 0.001. Triangles are
values from individual mice. Circles represent means and error bars
represent SEM.

were collected with EDTA (final concentration: 1.8 mg/ml) and
centrifuged at 400 g for 20 minutes, 4 ̊C to prepare plasma. Plasma
cholesterol concentrations were measured using an enzymatic
kit (Cat # 439-17501; Wako Chemicals USA, Richmond, VA, USA).

Quantification of aortic dilation and atherosclerosis

Aortas were dissected, fixed, cleaned, and pinned. Maximal
outer diameter of the suprarenal aorta was measured ex vivo as a
parameter for aortic dilation using Image-Pro software (Version
7; Media Cybernetics, Bethesda, MD, USA).
Thoracic aortas were cut open and pinned for quantification
of intimal area and atherosclerotic lesion area in the ascending
aorta, aortic arch and the proximal descending aorta using an
en face technique [14,15]. Atherosclerotic lesions, calculated
as percent lesion area (lesion area/intimal area x 100%), were
compared between groups following the recommended approach
described in the AHA statement [16].
Ann Vasc Med Res 7(1): 1099 (2020)

Data are represented as means ± standard errors of means
(SEM). To compare two groups on a continuous variable
after termination, unpaired two-sided Student’s t test was
performed for normally distributed and equally variant values
and Mann-Whitney rank sum test was used for variables not
passing normality or equal variance test. Plasma cholesterol
concentrations and luminal diameters of suprarenal aortas
measured by ultrasonography at a series of time points were
analyzed using linear mixed-effects models to compare trends
over time among the sub-groups within the cohort, with random
effects accounting for within-animal correlation. In general,
unstructured correlation matrix with unequal variances was
assumed to account for dependence among observations
over time and within mice. Models were built using R version
3.3.2 statistical software. P < 0.05 was considered statistically
significant.

Hypercholesterolemia accelerated the initiation of
AngII-induced AAAs
Male LDL receptor -/- mice (N = 10/group) were randomized
into two groups: WD group initiated Western diet one week
prior to AngII infusion, and ND - WD group initiated this diet
one week after AngII infusion was started (Figure 1A). Three
mice in WD group were excluded for data analysis due to aortic
rupture. Plasma cholesterol concentrations increased rapidly to
approximately 1,000 mg/dl prior to the start of AngII infusion
in WD group, whereas plasma cholesterol concentrations
remained significantly lower within the first two weeks of AngII
infusion in ND - WD group (Figure 1B). During the first week
of AngII infusion, maximal luminal diameters of suprarenal
aortas were smaller in ND - WD group than in WD Group as
determined by ultrasonography P = 0.004. Luminal diameters
became comparable between the two groups on 2 - 6 weeks
of AngII infusion (Figure 1C), as were also validated by ex vivo
measurements after termination (Figure 1D). Consistent with the
less duration of hypercholesterolemia, atherosclerotic lesions
were smaller in ND - WD group than in WD group (Figure 1E).

Hypercholesterolemia augmented the progression of
established AngII-induced AAAs

Seventy-nine male LDL receptors -/- mice were fed Western
diet for one week prior to AngII infusion. The interval of AngII
infusion was 4 weeks when Western diet continued. Eight mice
died of aortic rupture during the 4 weeks of AngII infusion. Four
weeks after AngII infusion 33 mice of the remaining 71 mice were
stratified into two groups based on maximal luminal diameters (≥
50% than baseline) of suprarenal aortas measured by ultrasound.
Mice in WD group were fed Western diet continuously and diet
for WD - ND group was changed from Western diet to normal
laboratory diet (Figure 2A). AngII infusion continued for another
8 weeks among these 33 mice. Two mice were excluded for data
analysis due to abdominal aortic rupture. Therefore, 16 mice in
WD group and 15 mice in WD - ND group were included for data
analyses. Plasma cholesterol concentrations decreased rapidly in
WD - ND group within one week after diet change and remained
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low during the remaining interval of AngII infusion (Figure 2B).
Maximal luminal diameters of suprarenal aortas continuously
increased in WD group, but remained constant during the rest
8 weeks of AngII infusion in WD - ND group (Figure 2C). This
significant effect of aortic diameters detected using ultrasound
was confirmed after termination by ex vivo measurements
(Figure 2D). Consistent with attenuation of hypercholesterolemia,
atherosclerotic lesion sizes were smaller in WD - ND group than
in WD group (Figure 2E).

DISCUSSION

This study has demonstrated that hypercholesterolemia
accelerates the initiation of AAAs and augments the progression
of established AAAs in AngII-infused mice. This was demonstrated
using male LDL receptor -/- mice fed normal laboratory
diet or Western diet that rapidly change plasma cholesterol
concentrations [3]. This study not only confirmed previous
reports that Western diet feeding quickly increased plasma
cholesterol concentrations [3,8,10], but also provided evidence
that plasma cholesterol concentrations reduced promptly after
Western diet was withdrawn in LDL receptor -/- mice.

In this study, we used atherosclerosis as a “positive” control
when we compared abdominal aortic dilation between groups
because atherosclerosis has positive association with the
magnitude and duration of hypercholesterolemia [3,16,17]. Mice
with either delayed Western diet feeding or removal of Western
diet had less atherosclerotic lesions, which were consistent
with lower plasma cholesterol concentrations or shorter
period of hypercholesterolemia. In contrast, the magnitude
of hypercholesterolemia did not affect development of AngIIinduced AAAs, but removal of hypercholesterolemia attenuated
the progression of established AAAs. These results are consistent
with our previous findings that hypercholesterolemia augmenting
AngII-induced AAAs has a threshold effect independent of the
absolute concentration of plasma total cholesterol [3]. In addition,
the present study provides evidence that hypercholesterolemia
accelerates AngII-induced AAAs during both the initiative and
the progressive stages. These findings support that inhibition of
hypercholesterolemia is critical to prevent AAA development and
attenuate the progression of established AAAs.
Many studies used apolipoprotein E deficient mice to explore
mechanisms of AngII-induced AAAs (a few examples from a large
number of publications [2,18-22]. This hypercholesterolemic
mouse strain is modestly hypercholesterolemic and does not
need Western diet to accelerate AngII-induced AAAs [3]. It
appears that this mouse strain leads to higher incidence and
mortality of AAAs, compared to LDL receptor -/- mice, although
plasma cholesterol concentrations in apolipoprotein E -/- mice
fed normal laboratory diet are much lower (~ 300 - 400 mg/dl)
compared to LDL receptor -/- mice fed Western diet (> 1000 mg/
dl),3 implicating more complex mechanisms of AngII-induced
AAAs in apolipoprotein E -/- mice. Therefore, LDL receptor -/mice have benefits to study contributions of hypercholesterolemia
and its related mechanisms to AngII-induced AAAs.
The present study provides guide for using AngII-induced AAA
model: A pre-existing hypercholesterolemic condition accelerates
AngII-induced AAAs in LDL receptor -/- mice. Therefore, our
Ann Vasc Med Res 7(1): 1099 (2020)

standard protocol to feed mice one week of Western diet prior to
AngII infusion is optimal.7 Second, to continuously feed Western
diet in LDL receptor -/- mice during AngII infusion is suggested
since hypercholesterolemia is important for the progression of
established AAAs. Dissecting effects of hypercholesterolemia
in the human disease is a cost, effort, and time-consuming task,
which involves many uncontrolled compound factors. Beyond
being a guide how to use this AngII-induced AAA mouse model
appropriately, this study, combined with our previous studies,
also provides insights into understanding whether and how
hypercholesterolemia contributes to AAAs in humans [3,23,24].

FUNDING SOURCE

The authors’ research work was supported by the National
Institutes of Health under award number R01HL133723 and
HL139748. Hisashi Sawada is supported by an American Heart
Association postdoctoral fellowship (18POST33990468). The
content in this manuscript is solely the responsibility of the
authors and does not necessarily represent the official views of
the National Institutes of Health.

REFERENCES

1. Daugherty A, Cassis L. Chronic angiotensin II infusion promotes
atherogenesis in low density lipoprotein receptor -/- mice. Ann N Y
Acad Sci. 1999; 892: 108-118.

2. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes
atherosclerotic lesions and aneurysms in apolipoprotein E-deficient
mice. J Clin Invest. 2000; 105: 1605-1612.
3. Liu J, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Sorci-Thomas
M, et al. Associations of apoAI and apoB-containing lipoproteins with
AngII-induced abdominal aortic aneurysms in mice. Arterioscler
Thromb Vasc Biol. 2015; 35: 1826-1834.
4. Lu H, Howatt DA, Balakrishnan A, Graham MJ, Mullick AE, Daugherty A.
Hypercholesterolemia induced by a PCSK9 gain-of-function mutation
augments angiotensin II-induced abdominal aortic aneurysms in
C57BL/6 mice. Arterioscler Thromb Vasc Biol. 2016; 36: 1753-1757.

5. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M,
Thinnes T, et al. Urokinase-type plasminogen activator plays a critical
role in angiotensin II-induced abdominal aortic aneurysm. Circ Res.
2003; 92: 510-517.
6. Uchida HA, Poduri A, Subramanian V, Cassis LA, Daugherty A.
Urokinase-type plasminogen activator deficiency in bone marrowderived cells augments rupture of angiotensin II-induced abdominal
aortic aneurysms. Arterioscler Thromb Vasc Biol. 2011; 31: 28452852.

7. Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Rateri DL, Cassis
LA, et al. Subcutaneous angiotensin II infusion using osmotic pumps
induces aortic aneurysms in mice. J Vis Exp. 2015; 103: e53191.

8. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive
xanthomatosis and atherosclerosis in cholesterol-fed low density
lipoprotein receptor-negative mice. J Clin Invest. 1994; 93: 18851893.

9. Tsukamoto K, Tangirala RK, Chun S, Usher D, Pure E, Rader DJ. Hepatic
expression of apolipoprotein E inhibits progression of atherosclerosis
without reducing cholesterol levels in LDL receptor-deficient mice.
Mol Ther. 2000; 1: 189-194.
10. Bjorklund MM, Hollensen AK, Hagensen MK, Dagnaes-Hansen F,
Christoffersen C, Mikkelsen JG, et al. Induction of atherosclerosis in
mice and hamsters without germline genetic engineering. Circ Res.

4/5

Liu J, et al. (2020)

Central
2014; 114: 1684-1689.

11. Robinet P, Milewicz DM, Cassis LA, Leeper NJ, Lu HS, Smith
JD. Consideration of sex differences in design and reporting of
experimental arterial pathology studies-Statement From ATVB
Council. Arterioscler Thromb Vasc Biol. 2018; 38: 292-303.
12. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA.
Androgen increases AT1a receptor expression in abdominal aortas
to promote angiotensin II-induced AAAs in apolipoprotein E-deficient
mice. Arterioscler Thromb Vasc Biol. 2008; 28: 1251-1256.
13. Sawada H, Chen JZ, Wright BC, Moorleghen JJ, Lu HS, Daugherty A.
Ultrasound imaging of the thoracic and abdominal aorta in mice to
determine aneurysm dimensions. J Vis Exp. 2019; e59013.

14. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice.
Methods Mol Biol. 2003; 209: 293-309.
15. Daugherty A, Rateri DL. Development of experimental designs for
atherosclerosis studies in mice. Methods. 2005; 36: 129-138.

16. Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, GarciaCardena G, et al. Recommendation on design, execution, and reporting
of animal atherosclerosis studies: A Scientific Statement from the
American Heart Association. Arterioscler Thromb Vasc Biol. 2017; 37:
e131-e157.

17. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E,
et al. Low-density lipoproteins cause atherosclerotic cardiovascular
disease. 1. Evidence from genetic, epidemiologic, and clinical studies.
A consensus statement from the European Atherosclerosis Society
Consensus Panel. Eur Heart J. 2017; 38: 2459-2472.

18. Yoshihara T, Shimada K, Fukao K, Sai E, Sato-Okabayashi Y, Matsumori
R, et al. Omega 3 polyunsaturated fatty acids suppress the development
of aortic aneurysms through the inhibition of macrophage-mediated
inflammation. Circ J. 2015; 79: 1470-1478.
19. Umebayashi R , Uchida HA, Kakio Y, Subramanian V, Daugherty A,
Wada J. Cilostazol attenuates angiotensin II-induced abdominal aortic
aneurysms but not atherosclerosis in apolipoprotein E-deficient mice.
Arterioscler Thromb Vasc Biol. 2018; 38: 903-912.

20. Deguchi JO, Huang H, Libby P, Aikawa E, Whittaker P, Sylvan J, et al.
Genetically engineered resistance for MMP collagenases promotes
abdominal aortic aneurysm formation in mice infused with
angiotensin II. Lab Invest. 2009; 89: 315-326.

21. Moran CS, Biros E, Krishna SM, Wang Y, Tikellis C, Morton SK, et
al. Resveratrol inhibits growth of experimental abdominal aortic
aneurysm associated with upregulation of angiotensin-converting
enzyme 2. Arterioscler Thromb Vasc Biol. 2017; 37: 2195-2203.
22. Sawada H, Hao H, Naito Y, Oboshi M, Hirotani S, Mitsuno M, et al. Aortic
iron overload with oxidative stress and inflammation in human and
murine abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol.
2015; 35: 1507-1514.

23. Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Risk factors for
abdominal aortic aneurysms: a 7-year prospective study: the Tromso
Study, 1994-2001. Circulation. 2009; 119: 2202-2208.
24. Chun KC, Teng KY, Chavez LA, Van Spyk EN, Samadzadeh KM, Carson
JG, et al. Risk factors associated with the diagnosis of abdominal aortic
aneurysm in patients screened at a regional Veterans Affairs health
care system. Ann Vasc Surg. 2014; 28: 87-92.

Cite this article
Liu J, Sawada H, Howatt DA, Moorleghen JJ, Vsevolozhskaya O, et al. (2020) Hypercholesterolemia Accelerates Both the Initiation and Progression of Angiotensin
II-induced Abdominal Aortic Aneurysms. Ann Vasc Med Res 7(1): 1099.

Ann Vasc Med Res 7(1): 1099 (2020)

5/5

